Back to top

medical-devices: Archive

Zacks Equity Research

RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand

Resmed shares rise after Q2 EPS and revenues beat expectations, with the gross and operating margins expanding sharply across core segments.

ISRGNegative Net Change ALGNNegative Net Change RMDNegative Net Change PAHCPositive Net Change

Zacks Equity Research

DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features

Dexcom plans a nationwide AI upgrade to Stelo, adding a million-plus food database and smarter insights to improve glucose understanding and wellness goals.

BSXNegative Net Change DXCMNegative Net Change ATRCPositive Net Change VCYTNegative Net Change

Zacks Equity Research

Can Sustained Product Demand Drive BDX Stock Before Q1 Earnings?

BD rides on sustained product demand across Medical, Life Sciences and Interventional, but China market dynamics may pressure first-quarter fiscal 2026 results.

BDXNegative Net Change MASINegative Net Change MMSINegative Net Change GMEDPositive Net Change

Indrajit Bandyopadhyay

Can Intuitive Surgical Sustain Robust Top-line Growth in 2026?

ISRG posts 20.5% revenue growth in 2025, driven by higher procedure volumes and da Vinci 5 adoption, and guides for 13-15% procedure growth in 2026.

SYKNegative Net Change ISRGNegative Net Change ZBHPositive Net Change

Zacks Equity Research

CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains

CAH tops second-quarter fiscal 2026 EPS estimates by 10%, posts strong segment profits, and raises full-year earnings outlook, sending shares higher.

BSXNegative Net Change CAHNegative Net Change ATRCPositive Net Change PAHCPositive Net Change

Zacks Equity Research

ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down

Align Technology shares surge after Q4 EPS and revenues beat expectations, lifted by record Clear Aligner volumes, even as gross and operating margins fall.

ISRGNegative Net Change ALGNNegative Net Change RMDNegative Net Change GMEDPositive Net Change

Zacks Equity Research

Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.

CAHNegative Net Change MASINegative Net Change DXCMNegative Net Change MMSINegative Net Change

Zacks Equity Research

Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test

QTRX submits a 510(k) to the FDA for its multi-analyte blood test aimed at evaluating cognitive symptoms for possible Alzheimer's disease.

BSXNegative Net Change ATRCPositive Net Change VCYTNegative Net Change QTRXPositive Net Change

Zacks Equity Research

Here's Why You Should Add Masimo Stock to Your Portfolio Now

MASI targets 7%-10% revenue growth through 2028, sharp margin expansion and rising cash flow as intelligent monitoring and partnerships gain traction.

ANGOPositive Net Change ISRGNegative Net Change MASINegative Net Change VCYTNegative Net Change